Constance Draft examines BioNTech co-founders Ugur Sahin and Özlem Türeci's departure to launch a next-generation mRNA venture, amid fifty-seven percent net losses and declining COVID vaccine revenues. The episode explores market reactions, succession planning, and whether institutions survive without their architects.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI